Related Experiment Videos

Expression of endoglin (CD105) in tumor blood vessels

International Journal of Cancer

|April 30, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Endoglin-Directed CAR T Cells Comprehensively Target Tumors in Advanced Sarcomas.

Cancer immunology research·2025

Identification of unique molecular heterogeneity of human CD79, the signaling component of the human B cell antigen receptor (BCR), and synergistic potentiation of the CD79-targeted therapy of B cell tumors by co-targeting of CD79a and CD79b.

Leukemia research·2024

Endoglin inhibitor TRC105 with or without bevacizumab for bevacizumab-refractory glioblastoma (ENDOT): a multicenter phase II trial.

Communications medicine·2023

An Open Label Phase Ib Dose Escalation Study of TRC105 (Anti-Endoglin Antibody) with Axitinib in Patients with Metastatic Renal Cell Carcinoma.

The oncologist·2018

A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma.

Clinical genitourinary cancer·2016

An open-label phase Ib dose-escalation study of TRC105 (anti-endoglin antibody) with bevacizumab in patients with advanced cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2014

See all related articles